Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Cancer Hallmarks & Systems Biology

Harold Varmus

哈罗德·瓦尔慕斯

MD

🏢Weill Cornell Medicine(威尔康奈尔医学院)🌐USA

Lewis Thomas University Professor; Former NCI Director (2010–2015); Former NIH Director (1993–1999)刘易斯·托马斯大学教授;前美国国家癌症研究所所长(2010–2015);前美国国立卫生研究院院长(1993–1999)

170
h-index
3
Key Papers
6
Awards
3
Key Contributions

👥Biography 个人简介

Harold Varmus is one of the founding figures of modern cancer molecular biology. Together with his longtime collaborator J. Michael Bishop at UCSF, he demonstrated in the mid-1970s that the transforming gene (v-src) carried by Rous sarcoma virus — a known tumor-causing retrovirus — is not a viral creation but is instead a mutated version of a normal cellular gene present in the genomes of virtually all vertebrate animals. This revolutionary discovery gave birth to the concept of the proto-oncogene and earned Varmus and Bishop the 1989 Nobel Prize in Physiology or Medicine. Before Varmus and Bishop's work, the dominant theory held that oncogenic retroviruses brought foreign "cancer genes" into cells. Their findings overturned this view: normal cells carry ancestral versions of oncogenes (proto-oncogenes) that become activated through mutation, amplification, or chromosomal rearrangement during carcinogenesis. The implications were transformative — cancer is fundamentally a genetic disease arising from corruption of normal cellular regulatory programs. Varmus extended his molecular oncology research to investigate how retroviruses integrate into host genomes, leading to fundamental insights into HIV biology that informed antiviral drug development. He showed that retroviral integration is not random but is guided by specific viral and cellular factors. As NIH Director from 1993 to 1999 — one of the most consequential periods in modern biomedical science — Varmus championed fundamental research, oversaw a doubling of the NIH budget, and launched the National Center for Complementary and Alternative Medicine. He returned to run the NCI from 2010 to 2015, focusing on precision oncology and the Cancer Genome Atlas initiative. At Weill Cornell Medicine, Varmus continues research on the genetics of lung adenocarcinoma, particularly the roles of NKX2-1 (TTF-1) transcription factor and KRAS mutations in lung cancer initiation and maintenance. He is a leading voice for science policy, global health equity, and open-access publishing (having co-founded PubMed Central).

Harold Varmus 是现代癌症分子生物学的奠基人之一。他与 J. Michael Bishop 合作证明,劳斯肉瘤病毒携带的转化基因 v-src 并非病毒创造,而是脊椎动物基因组中正常细胞基因的突变版本,由此诞生了原癌基因的概念,并因此荣获1989年诺贝尔生理学或医学奖。 这一发现彻底推翻了癌症源于外来病毒基因的主流理论,确立了癌症是正常细胞调控程序被破坏所致的遗传性疾病这一范式。作为美国国立卫生研究院院长和国家癌症研究所所长,Varmus 深刻塑造了美国生物医学研究政策。在威尔康奈尔医学院,他继续研究肺腺癌的遗传学。

Share:

🧪Research Fields 研究领域

Proto-oncogenes原癌基因
Src KinaseSrc激酶
Cancer Genetics癌症遗传学
Science Policy科学政策

🎓Key Contributions 主要贡献

Discovery of Proto-oncogenes and the Cellular Origin of Oncogenes

Demonstrated with Bishop that the retroviral oncogene v-src derives from a conserved normal cellular gene (c-src) present across vertebrate evolution. This established that cancers arise from activation of endogenous proto-oncogenes — not from foreign viral genes — fundamentally reshaping cancer biology and earning the 1989 Nobel Prize in Physiology or Medicine.

Retroviral Integration Biology and HIV Research

Elucidated the mechanisms by which retroviruses integrate their DNA into host cell genomes, identifying the integrase enzyme as a therapeutic target. These insights directly informed the development of HIV integrase inhibitors (a major class of antiretroviral drugs).

Lung Cancer Genetics and NKX2-1/KRAS Biology

Identified NKX2-1 (TTF-1) as an oncogene amplified in lung adenocarcinomas that drives lineage-specific survival, and characterized how KRAS-mutant lung cancer cells depend on specific transcriptional programs for tumor maintenance, informing targeted therapy strategies.

Representative Works 代表性著作

[1]

DNA related to the transforming gene(s) of avian sarcoma viruses is present in normal avian DNA

Nature (1976)

The landmark paper with Bishop demonstrating that v-src oncogene sequences exist as c-src in normal vertebrate cells — founding the proto-oncogene concept.

[2]

NKX2-1 reprograms lung adenocarcinoma cells to a more mesenchymal identity to drive metastasis

Cell (2012)

Revealed dual roles of NKX2-1 in lung cancer as both a lineage survival factor and suppressor of metastasis, showing complex oncogene-suppressor functionality.

[3]

Retroviruses (Cold Spring Harbor Monograph)

Cold Spring Harbor Laboratory Press (1997)

The definitive textbook on retrovirus biology co-authored with Varmus, Coffin, and Hughes, remaining the foundational reference in the field.

🏆Awards & Recognition 奖项与荣誉

🏆Nobel Prize in Physiology or Medicine (1989, shared with J. Michael Bishop)
🏆National Medal of Science (2001)
🏆Lasker Award for Basic Medical Research (1982)
🏆Albert Lasker Special Achievement Award
🏆Member, National Academy of Sciences
🏆Member, American Academy of Arts and Sciences

📄Data Sources 数据来源

Last updated: 2026-04-05 | All information from publicly available academic sources

关注 哈罗德·瓦尔慕斯 的研究动态

Follow Harold Varmus's research updates

留下邮箱,当我们发布与 Harold Varmus(Weill Cornell Medicine)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment